Curis
CRIS
Curis (CRIS) news
Recent news
Curis, Inc.: H.C. Wainwright raises target price to $43 from $17
AInvest Wire · Jul 24, 2026Curis - to dose initial 5 TakeAim CLL patients by end of July; data expected December 2026
AInvest Wire · Jul 22, 2026Curis - reverse stock split approved at ratio of 1-for-5 to 1-for-25
Curis, Inc. (NASDAQ: CRIS) has proposed reverse stock split with flexible ratio ranging from 1-for-5 to 1-for-25, subject to shareholder approval at a special meeting scheduled for June 25, 2026. The corporate action, announced on June 5, 2025, aims to consolidate the company’s outstanding shares…
AInvest Wire · Jun 26, 2026Curis: eleven active clinical sites in TakeAim CLL study, reaffirms patient dosing guidance, reports stockholder approval of
AInvest Wire · Jun 26, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.